Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fibroblast activation protein inhibitor compounds and methods

Fibroblast activation protein inhibitor compounds and methods

US Patent 7399869 · Granted Jul 15, 2008

Estimated economic value: $147,919,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

3-substituted piperidine compounds for Cbl-b inhibition, and use thereof2025
Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses the2025
Macrocyclic compounds and methods of use thereof2025
Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses t2024
Cyano cyclobutyl compounds for Cbl-b inhibition and uses thereof2024
RET inhibitor for use in treating cancer having a RET alteration2024
Inhibitors of IAP2024
3-substituted piperidine compounds for Cbl-b inhibition, and use thereof2024
RET inhibitor for use in treating cancer having a RET alteration2024
Method and/or system for providing and/or analyzing and/or presenting decision s2023
PROTAC antibody conjugates and methods of use2023
Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhib2023